The US Food and Drugs Administration is removing 27 Abbreviated New Drug Application (ANDA) approvals held by generic drugs maker Ranbaxy Laboratories .
"The FDA is withdrawing approval of 27 ANDAs held by Ranbaxy...The drugs are no longer marketed...Ranbaxy requested withdrawl of approval...
